Why the study?
Critical factors and molecular mechanisms for translational control of pro-fibrotic genes during cardiac fibrosis remain unclear, prompting investigation into the role of glutamyl-prolyl-tRNA synthetase (EPRS).
Population
Human and mouse heart failure samples and mouse models
Comparison
Global or myofibroblast-specific Eprs knockout vs controls
Design
Preclinical experimental and animal model study
Authors
Loading...
EPRS inhibition reduced fibrosis in mice; hypothesis-generating for antifibrotic therapy in human HF.
EPRS is a critical translational regulator of proline-rich pro-fibrotic genes, and its inhibition significantly reduces pathological cardiac fibrosis in heart failure models.
Wu et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: